Terms: = Germ cell tumor AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
143 results:
1. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
Huang R; Kong Y; Luo Z; Li Q
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract] [Full Text] [Related]
4. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
5. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
6. Novel MED15::ATF1 fusion in a pediatric melanoma with spitzoid features and aggressive presentation.
Furtado LV; Cardenas M; Santiago T; Ruiz RE; Shi Z; Pappo A; Kacar M
Genes Chromosomes Cancer; 2024 Mar; 63(3):e23230. PubMed ID: 38459940
[TBL] [Abstract] [Full Text] [Related]
7. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract] [Full Text] [Related]
8. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
9. Protein Disulfide Isomerase A2 Is Correlated with Immune Infiltrates and Is a Novel Prognostic Biomarker in Glioma Patients.
Ma ZG; Liu YX; Zou N; Huang Z; Wang M; Li T; Zhou J; Chen LG
Curr Med Sci; 2023 Dec; 43(6):1107-1115. PubMed ID: 37978154
[TBL] [Abstract] [Full Text] [Related]
10. The Glioblastoma CircularRNAome.
Tirpe A; Streianu C; Tirpe SM; Kocijancic A; Pirlog R; Pirlog B; Busuioc C; Pop OL; Berindan-Neagoe I
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833993
[TBL] [Abstract] [Full Text] [Related]
11. [Molecular Characteristics and Clinical Significance of germ cell tumors].
Takami H
No Shinkei Geka; 2023 Sep; 51(5):892-900. PubMed ID: 37743341
[TBL] [Abstract] [Full Text] [Related]
12. Glioma genetic profiles associated with electrophysiologic hyperexcitability.
Tobochnik S; Dorotan MKC; Ghosh HS; Lapinskas E; Vogelzang J; Reardon DA; Ligon KL; Bi WL; Smirnakis SM; Lee JW
Neuro Oncol; 2024 Feb; 26(2):323-334. PubMed ID: 37713468
[TBL] [Abstract] [Full Text] [Related]
13. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract] [Full Text] [Related]
15. Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
Han W; Chen L
Mol Carcinog; 2023 Jul; 62(7):975-990. PubMed ID: 37036189
[TBL] [Abstract] [Full Text] [Related]
16. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
17. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract] [Full Text] [Related]
18.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
19. Papillary Intralymphatic Angioendothelioma in a Child With
Debelenko L; Mansukhani MM; Remotti F
Pediatr Dev Pathol; 2023; 26(2):166-171. PubMed ID: 36775953
[TBL] [Abstract] [Full Text] [Related]
20. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
[TBL] [Abstract] [Full Text] [Related]
[Next]
